Income Tax Expense (Benefit) in USD of REGENEREX PHARMA, INC. from 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
REGENEREX PHARMA, INC. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2024 to Q3 2025.
  • REGENEREX PHARMA, INC. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was -$50.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

REGENEREX PHARMA, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$50 01 Jul 2025 30 Sep 2025 10-Q 17 Nov 2025
Q2 2025 -$113 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025

REGENEREX PHARMA, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2,717 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.